• Professional Development
  • Medicine & Nursing
  • Arts & Crafts
  • Health & Wellbeing
  • Personal Development

1288 Educators providing Clinical courses

Boa Training

boa training

Wickford

The first BOA Training and Education Strategy document was published in 2012. It set out an action centred approach to development work across four community domains and eleven projects. A year later we have taken the opportunity to refresh the strategy in the light of work completed, and some new initiatives reflecting the ever changing dynamic of surgical training and education. The BOA focuses its training and education resources on: Development of the T&O specialty training curriculum. Construction and delivery of an annual trainee instructional course, geared to a four year FRCS (Tr and Orth) cycle. Awards of fellowships and prizes. CESR courses for SAS surgeons aspiring to gain entry to the specialist register. Delivery of training the trainer and educational supervisor instructional courses. Delivery of MSK clinical assessment skills courses for those in Core Training. Revalidation of all T&O surgeons through our annual Congress with a series of clinical and other instructional content geared to a five year cycle. The development of our e-learning capability for both specialty training and broader revalidation purposes. The need for continuing pace The shape and diversity of the healthcare work force is evolving rapidly: all elements are doing more with less in order to contain NHS expenditure at a sustainable level. T&O in particular faces a unique set of challenges and the BOA has developed an action plan through which to address them: full details are contained in our Practice Strategy. Focused on high quality care for patients against the backdrop of a 15% and growing capacity gap in elective orthopaedics, the action plan highlights the need for better patient pathways, enhanced implant surveillance, strong partnerships between providers of acute care, multidisciplinary teams working seamlessly across the primary and secondary care divide, and clinical culture change within the T&O community. All this needs to be instilled in surgeons from the outset of their careers, and the challenge for the BOA as a Surgical Specialty Association is to identify, recruit, educate and nurture the best talent from medical schools and throughout their formative and specialty training in order to create sufficient: High quality T&O capacity with surgical capability in depth to meet future demand. Future clinical academic capacity to sustain the UK’s T&O research capability. The rationale for this is set out in the BOA Research Strategy In addition, we need to: Care better for our patients throughout their treatment pathways by engaging effectively and productively with General Practitioners, Nurses and Allied Health Professionals with an interest in orthopaedics. Accordingly we continue to broaden the scope of our training and education work. This will be essential if we are to encompass more fully the needs of the T&O community and the wider musculoskeletal multi-disciplinary team. Achieving this through an action centred, project based approach to Training and Education .

Newcastle University (on behalf of Conect4Children)

newcastle university (on behalf of conect4children)

Newcastle upon Tyne

c4c (conect4children) is a large collaborative European network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population. It is a pioneering opportunity to build capacity for the implementation of multinational paediatric clinical trials whilst ensuring the needs of babies, children, young people and their families are met. c4c is committed to meeting the needs of paediatric patients thanks to a novel collaboration between the academic and the private sectors, which includes 35 academic and 10 industry partners and around 500 affiliated partners. c4c endeavours to provide a sustainable, integrated platform for the efficient and swift delivery of high quality clinical trials in children and young people across all conditions and phases of the drug development process. c4c strives to bring innovative processes to all stages of clinical development by generating a new model of organization and of the clinical development process. By emphasizing inclusiveness and collaboration across geographical, specialty, sectoral, cultural and societal backgrounds, it will set up a new infrastructure to support all evaluations of medicines in children. In this manner, it will become a benchmark in the currently fragmented European clinical research environment. Best practices and up-to-date expert advice will inform the c4c approaches and methods, which will subsequently be refined in the context of viability trials.